MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
435.94%
Quick Ratio
435.94%
Cash Ratio
381.03%
Debt to Asset Ratio
26.78%
Unit: Dollar
Assets Breakdown
    • Operating lease right-of-use ass...
    • Tax credits
    • Restricted cash
    • Long-term deposits and other non...
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accounts payable
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
13,084,144
16,539,222
20,837,628
8,807,353
Tax credits
210,494
231,003
179,701
271,515
Prepaid expenses and other current assets
1,675,110
1,451,543
1,219,809
1,438,400
Total current assets
14,969,748
18,221,768
22,237,138
10,517,268
Property and equipment, net
47,026
54,435
74,916
85,572
Internal-use software, net
76,782
90,045
102,837
114,607
Operating lease right-of-use assets
266,861
300,576
334,090
184,422
Restricted cash
35,589
36,085
36,296
36,117
Long-term deposits and other noncurrent assets
25,933
35,555
33,698
33,694
Total noncurrent assets
452,191
516,696
581,837
454,412
Total assets
15,421,939
18,738,464
22,818,975
10,971,680
Accounts payable
1,220,365
1,516,362
825,027
1,577,151
Operating lease liabilities - current
109,428
116,627
119,876
115,910
Other current liabilities
1,980,444
2,153,304
2,306,624
2,340,703
Deferred grant income - current
-
-
-
11,293
Loans - current
123,628
100,281
100,869
125,545
Total current liabilities
3,433,865
3,886,574
3,352,396
4,170,602
Defined benefit pension plan
319,225
389,519
390,509
527,825
Operating lease liabilities - noncurrent
156,760
182,129
211,238
65,026
Loans - noncurrent
220,058
273,265
300,084
298,797
Total noncurrent liabilities
696,043
844,913
901,831
891,648
Total liabilities
4,129,908
4,731,487
4,254,227
5,062,250
Common stock, 0.0001 par value 100,000,000 shares authorized 43,340,501 and 42,073,807 shares issued and outstanding as of june 30, 2026 and december 31, 2025, respectively
4,335
4,250
4,209
3,599
Additional paid-in capital
121,924,254
119,970,514
119,139,677
102,161,036
Accumulated other comprehensive income
1,003,752
996,952
776,869
563,221
Accumulated deficit
-111,640,310
-101,356,007
-81,194,908
-81,194,908
Loss of the period
-
-5,608,732
-20,161,099
-15,623,518
Total stockholders' equity
11,292,031
14,006,977
18,564,748
5,909,430
Total liabilities and stockholders' equity
15,421,939
18,738,464
22,818,975
10,971,680
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$13,084,144 (95.46%↑ Y/Y)Prepaid expenses andother current assets$1,675,110 (-27.00%↓ Y/Y)Tax credits$210,494 (-33.77%↓ Y/Y)Operating leaseright-of-use assets$266,861 (14.43%↑ Y/Y)Internal-use software, net$76,782 (-39.95%↓ Y/Y)Property and equipment,net$47,026 (-51.11%↓ Y/Y)Restricted cash$35,589 (-1.90%↓ Y/Y)Long-term deposits andother noncurrent...$25,933 (-23.17%↓ Y/Y)Total current assets$14,969,748 (60.85%↑ Y/Y)Total noncurrentassets$452,191 (-14.24%↓ Y/Y)Total assets$15,421,939 (56.82%↑ Y/Y)Total liabilities andstockholders' equity$15,421,939 (56.82%↑ Y/Y)Total stockholders'equity$11,292,031 (205.52%↑ Y/Y)Total liabilities$4,129,908 (-32.71%↓ Y/Y)Accumulated deficit-$111,640,310 (-37.50%↓ Y/Y)Additional paid-in capital$121,924,254 (28.83%↑ Y/Y)Total currentliabilities$3,433,865 (-33.93%↓ Y/Y)Total noncurrentliabilities$696,043 (-26.02%↓ Y/Y)Accumulated othercomprehensive income$1,003,752 (71.85%↑ Y/Y)Common stock, 0.0001par value...$4,335 (40.84%↑ Y/Y)Other currentliabilities$1,980,444 (-9.94%↓ Y/Y)Accounts payable$1,220,365 (-55.02%↓ Y/Y)Loans - current$123,628 (-1.97%↓ Y/Y)Operating leaseliabilities - current$109,428 (-19.73%↓ Y/Y)Defined benefit pensionplan$319,225 (-38.92%↓ Y/Y)Loans - noncurrent$220,058 (-32.36%↓ Y/Y)Operating leaseliabilities - noncurrent$156,760 (68.83%↑ Y/Y)

Gain Therapeutics, Inc. (GANX)

Gain Therapeutics, Inc. (GANX)